Adicet Share Price

Adicet Share Price

NASDAQ: ACET | Micro Cap | Healthcare
$2.50
-$0.27 (-9.58%) Last updated on 19 Nov, 2026 | 01:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • Similar Stocks
  • FAQs

Adicet Stock Performance

Open
$2.73
Prev. Close
$2.77
Circuit Range
N/A
Day Range
$2.41 - $2.78
Year Range
$0.46 - $9.84
Volume
19,830
Average Traded
$2.60

Adicet Share Price Today

As of 19 November 2026, Adicet Bio, Inc.'s share price is $2.50. The stock opened at $2.73, compared to its previous close of $2.77. During today's trading session, Adicet Bio, Inc.'s share price traded between $2.41 and $2.78, with an average price of $2.59. Over the past 52 weeks, the stock has recorded a high of $9.84 and a low of $0.46. In terms of performance, Adicet Bio, Inc.'s share price has declined by 73.35% over the last six months and is up 284.02% on a year-on-year basis.

Adicet Share Price Chart

Line chart of the Adicet price trend over the selected period. The price fell overall, ranging from 2.40 to 2.80, ending at 2.50.
$2.41$2.78
L
Show Current Price
H

Adicet Stock Fundamentals & Key Indicators

Market Cap
$17.23M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-9.72
Revenue (TTM)
$0.00
Return On Equity (TTM)
-88.61%
Profit Margin
N/A
Debt to Equity
0.01
Quarterly Earnings Growth YoY
38.14%

Adicet Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$30.52-$20.24-$21.36-$18.88
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A33.68%-5.53%11.61%

Adicet Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$24.99$0.00$0.00$0.00
Net Profit-$69.79-$142.66-$117.12-$116.80
Net Profit Margin-279.27%N/AN/AN/A
Income ChangeN/A-104.41%17.90%0.27%

Adicet Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets31.4340.0845.0269.65
Current Assets160.93180.14162.27261.04
Total Assets192.36220.22207.3330.69
Non Current Liabilities11.6114.2217.8318.65
Current Liabilities21.5319.3919.2919.71
Total Liabilities33.1533.6137.1238.35
Shareholders' Equity159.21186.61170.18292.34

Adicet Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-95.25-92.38-93.72-44.77
Investing2.39-119.24-4.46-16.78
Financing75.25111.310.2441.51

Corporate Actions

Split
Ex-date: 30 Dec 2025

About Adicet

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Adicet Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.42
$2.48
-26.84%
Oct 2026
$6.84
$3.39
-52.82%
Sep 2026
$8.90
$7.18
-19.54%
Aug 2026
$9.10
$8.93
-2.08%
Jul 2026
$8.91
$9.12
+5.68%
Jun 2026
$9.17
$8.63
-8.00%
May 2026
$7.60
$9.38
+24.32%
Apr 2026
$6.96
$7.54
+11.12%
Mar 2026
$7.14
$6.79
-5.96%
Feb 2026
$7.91
$7.22
-9.41%
Jan 2026
$8.62
$7.97
-5.23%
Dec 2025
$0.62
$8.41
+1,191.86%

Adicet Share Price FAQs